Agios Pharmaceuticals Inc
NASDAQ:AGIO

Watchlist Manager
Agios Pharmaceuticals Inc Logo
Agios Pharmaceuticals Inc
NASDAQ:AGIO
Watchlist
Price: 32.09 USD 0.79% Market Closed
Market Cap: 1.9B USD

EV/S
Enterprise Value to Sales

26
Current
43.1
Median
7.4
Industry
Lower than median
Higher than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
26
=
Enterprise Value
964.2m USD
/
Revenue
37m USD

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
20.7
2-Years Forward
EV/S
7.2
3-Years Forward
EV/S
3